Koeffler HP - Search Results

1

Targeted siRNA nanocarrier: a platform technology for cancer treatment.

Bäumer N, Tiemann J, Scheller A, Meyer T, Wittmann L, Suburu MEG, Greune L, Peipp M, Kellmann N, Gumnior A, Brand C, Hartmann W, Rossig C, Müller-Tidow C, Neri D, Strassert CA, Rüter C, Dersch P, Lenz G, Koeffler HP, Berdel WE, Bäumer S. Bäumer N, et al. Among authors: koeffler hp. Oncogene. 2022 Apr;41(15):2210-2224. doi: 10.1038/s41388-022-02241-w. Epub 2022 Feb 26. Oncogene. 2022. PMID: 35220407 Free PMC article.

2

A potential transcriptional activation element in the p53 protein.

O'Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen DL, Dang CV, Koeffler HP. O'Rourke RW, et al. Among authors: koeffler hp. Oncogene. 1990 Dec;5(12):1829-32. Oncogene. 1990. PMID: 2284102

3

Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes.

Lübbert M, Miller CW, Kahan J, Koeffler HP. Lübbert M, et al. Among authors: koeffler hp. Oncogene. 1989 May;4(5):643-51. Oncogene. 1989. PMID: 2657579

4

Carcinoma of the vulva: HPV and p53 mutations.

Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP. Lee YY, et al. Among authors: koeffler hp. Oncogene. 1994 Jun;9(6):1655-9. Oncogene. 1994. PMID: 8183560

5

Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.

Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL, Koeffler HP. Park DJ, et al. Among authors: koeffler hp. Oncogene. 1994 Jul;9(7):1899-906. Oncogene. 1994. PMID: 8208536

6

Analysis of p53 transactivation through high-affinity binding sites.

Chumakov AM, Miller CW, Chen DL, Koeffler HP. Chumakov AM, et al. Among authors: koeffler hp. Oncogene. 1993 Nov;8(11):3005-11. Oncogene. 1993. PMID: 8414502

7

The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma.

Miller CW, Yeon C, Aslo A, Mendoza S, Aytac U, Koeffler HP. Miller CW, et al. Among authors: koeffler hp. Oncogene. 1997 Jul 10;15(2):231-5. doi: 10.1038/sj.onc.1201185. Oncogene. 1997. PMID: 9244358

8

Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent.

Müller C, Readhead C, Diederichs S, Idos G, Yang R, Tidow N, Serve H, Berdel WE, Koeffler HP. Müller C, et al. Among authors: koeffler hp. Mol Cell Biol. 2000 May;20(9):3316-29. doi: 10.1128/MCB.20.9.3316-3329.2000. Mol Cell Biol. 2000. PMID: 10757815 Free PMC article.

9

The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia.

Müller C, Yang R, Park DJ, Serve H, Berdel WE, Koeffler HP. Müller C, et al. Among authors: koeffler hp. Blood. 2000 Dec 1;96(12):3894-9. Blood. 2000. PMID: 11090075 Free article.

10

Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.

Müller-Tidow C, Metzger R, Kügler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B, Schneider PM, Koeffler HP, Berdel WE, Serve H. Müller-Tidow C, et al. Among authors: koeffler hp. Cancer Res. 2001 Jan 15;61(2):647-53. Cancer Res. 2001. PMID: 11212263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

844 results

Search Page